Beneficial effects of a Q-terh® based nutritional mixture on functional performance, mitochondrial function, and oxidative stress in rats

PLoS ONE

Volumn 5, Issue 5, 2010, Pages

  Xu, Jinze ^a   Seo, Arnold Y ^a   Vorobyeva, Darya A ^a   Carter, Christy S ^a   Anton, Stephen D ^a   Lezza, Angela M S ^b   Leeuwenburgh, Christiaan ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ASPARTATE POTASSIUM; CREATINE; CYANOCOBALAMIN; DNA; GINSENG EXTRACT; MAGNESIUM ASPARTATE; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; MITOCHONDRIAL PROTEIN; NICOTINAMIDE; PANTOTHENATE CALCIUM; POTASSIUM SALT; PYRIDOXINE; RIBOFLAVIN; RNA; SUCROSE; THIAMINE; UBIDECARENONE; UNCLASSIFIED DRUG; URIC ACID;

AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BODY WEIGHT; BROWN NORWAY RAT; CELLULAR, SUBCELLULAR AND MOLECULAR BIOLOGICAL PHENOMENA AND FUNCTIONS; CONTROLLED STUDY; DIET SUPPLEMENTATION; DNA OXIDATION; FERRIC REDUCING ANTIOXIDANT POWER; FOOD INTAKE; GASTROCNEMIUS MUSCLE; GRIP STRENGTH; MALE; MITOCHONDRIA CALCIUM RETENTION CAPACITY; MUSCLE MASS; MUSCLE MITOCHONDRION; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PHYSICAL PERFORMANCE; PROTEIN CARBONYLATION; RAT; RNA OXIDATION; SARCOLEMMA; TOTAL URINE ANTIOXIDANT POWER;

ANIMALS; ANTIOXIDANTS; BODY WEIGHT; CALCIUM; CROSSES, GENETIC; DIETARY SUPPLEMENTS; DNA; FEEDING BEHAVIOR; FEMALE; HAND STRENGTH; IRON; MALE; MITOCHONDRIA; MUSCLES; NUTRITIONAL PHYSIOLOGICAL PHENOMENA; ORGAN SIZE; OXIDATION-REDUCTION; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, INBRED BN; RATS, INBRED F344; RNA; SARCOLEMMA; UBIQUINONE;

ANIMALIA; PANAX GINSENG; RATTUS; RATTUS NORVEGICUS;

EID: 77956398495     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0010572     Document Type: Article

References (91)

1. Leeuwenburgh C, Prolla TA (2006) Genetics, redox signaling, oxidative stress, and apoptosis in mammalian aging. Antioxid Redox Signal 8: 503-505.
2. Hofer T, Marzetti E, Xu J, Seo AY, Gulec S, et al. (2008) Increased iron content and RNA oxidative damage in skeletal muscle with aging and disuse atrophy. Exp Gerontol 43: 563-570.
3. Muller FL, Lustgarten MS, Jang Y, Richardson A, Van RH (2007) Trends in oxidative aging theories. Free Radic Biol Med 43: 477-503.
4. Carter CS, Leeuwenburgh C, Daniels M, Foster TC (2009) Influence of calorie restriction on measures of age-related cognitive decline: role of increased physical activity. J Gerontol A Biol Sci Med Sci 64: 850-859.
5. Miquel J, Economos AC, Fleming J, Johnson JE, Jr. (1980) Mitochondrial role in cell aging. Exp Gerontol 15: 575-591.
6. Harman D (2006) Free radical theory of aging: an update: increasing the functional life span. Ann N Y Acad Sci 1067: 10-21.
7. Rodriguez MC, MacDonald JR, Mahoney DJ, Parise G, Beal MF, et al. (2007) Beneficial effects of creatine, CoQ10, and lipoic acid in mitochondrial disorders. Muscle Nerve 35: 235-242.
8. Zhou C, Huang Y, Przedborski S (2008) Oxidative stress in Parkinson's disease: a mechanism of pathogenic and therapeutic significance. Ann N Y Acad Sci 1147: 93-104.
9. Tarnopolsky MA (2008) The mitochondrial cocktail: rationale for combined nutraceutical therapy in mitochondrial cytopathies. Adv Drug Deliv Rev 60: 1561-1567.
10. Werbach MR (2000) Nutritional strategies for treating chronic fatigue syndrome. Altern Med Rev 5: 93-108.
11. Bentler SE, Hartz AJ, Kuhn EM (2005) Prospective observational study of treatments for unexplained chronic fatigue. J Clin Psychiatry 66: 625-632.
12. Schmelzer C, Lorenz G, Rimbach G, Doring F (2009) In Vitro Effects of the Reduced Form of Coenzyme Q(10) on Secretion Levels of TNF-alpha and Chemokines in Response to LPS in the Human Monocytic Cell Line THP-1. J Clin Biochem Nutr 44: 62-66.
13. Mahoney DJ, Parise G, Tarnopolsky MA (2002) Nutritional and exercise-based therapies in the treatment of mitochondrial disease. Curr Opin Clin Nutr Metab Care 5: 619-629.
14. Marriage B, Clandinin MT, Glerum DM (2003) Nutritional cofactor treatment in mitochondrial disorders. J Am Diet Assoc 103: 1029-1038.
15. Takahashi T, Okamoto T, Mori K, Sayo H, Kishi T (1993) Distribution of ubiquinone and ubiquinol homologues in rat tissues and subcellular fractions. Lipids 28: 803-809.
16. Littarru GP, Tiano L (2007) Bioenergetic and antioxidant properties of coenzyme Q10: recent developments. Mol Biotechnol 37: 31-37.
17. Papucci L, Schiavone N, Witort E, Donnini M, Lapucci A, et al. (2003) Coenzyme q10 prevents apoptosis by inhibiting mitochondrial depolarization independently of its free radical scavenging property. J Biol Chem 278: 28220-28228.
18. Seo AY, Xu J, Servais S, Hofer T, Marzetti E, et al. (2008) Mitochondrial iron accumulation with age and functional consequences. Aging Cell 7: 706-716.
19. Lemasters JJ, Theruvath TP, Zhong Z, Nieminen AL (2009) Mitochondrial calcium and the permeability transition in cell death. Biochim Biophys Acta 1787: 1395-1401.
20. Baumgartner HK, Gerasimenko JV, Thorne C, Ferdek P, Pozzan T, et al. (2009) Calcium elevation in mitochondria is the main Ca2+ requirement for mitochondrial permeability transition pore (mPTP) opening. J Biol Chem 284: 20796-20803.
21. Li G, Zou LY, Cao CM, Yang ES (2005) Coenzyme Q10 protects SHSY5Y neuronal cells from beta amyloid toxicity and oxygen-glucose deprivation by inhibiting the opening of the mitochondrial permeability transition pore. Biofactors 25: 97-107.
22. Sahach VF, Vavilova HL, Rudyk OV, Dobrovol's'kyi FV, Shymans'ka TV, et al. (2007) Inhibition of mitochondrial permeability transition pore is one of the mechanisms of cardioprotective effect of coenzyme Q10. Fiziol Zh 53: 35-42.
23. Cordero MD, Moreno-Fernandez AM, Gomez-Skarmeta JL, de MM, Garrido-Maraver J, et al. (2009) Coenzyme Q10 and alpha-tocopherol protect against amitriptyline toxicity. Toxicol Appl Pharmacol 235: 329-337.
24. Beal MF (2004) Therapeutic effects of coenzyme Q10 in neurodegenerative diseases. Methods Enzymol 382: 473-487.
25. Beal MF (2003) Bioenergetic approaches for neuroprotection in Parkinson's disease. Ann Neurol 53 Suppl 3: S39-S47.
26. McCarthy S, Somayajulu M, Sikorska M, Borowy-Borowski H, Pandey S (2004) Paraquat induces oxidative stress and neuronal cell death; neuroprotection by water-soluble Coenzyme Q10. Toxicol Appl Pharmacol 201: 21-31.
27. Moon Y, Lee KH, Park JH, Geum D, Kim K (2005) Mitochondrial membrane depolarization and the selective death of dopaminergic neurons by rotenone: protective effect of coenzyme Q10. J Neurochem 93: 1199-1208.
28. Kooncumchoo P, Sharma S, Porter J, Govitrapong P, Ebadi M (2006) Coenzyme Q(10) provides neuroprotection in iron-induced apoptosis in dopaminergic neurons. J Mol Neurosci 28: 125-141.
29. Beal MF, Matthews RT, Tieleman A, Shults CW (1998) Coenzyme Q10 attenuates the 1-methyl-4-phenyl-1,2,3,tetrahydropyridine (MPTP) induced loss of striatal dopamine and dopaminergic axons in aged mice. Brain Res 783: 109-114.
30. Cleren C, Yang L, Lorenzo B, Calingasan NY, Schomer A, et al. (2008) Therapeutic effects of coenzyme Q10 (CoQ10) and reduced CoQ10 in the MPTP model of Parkinsonism. J Neurochem 104: 1613-1621.
31. Fetoni AR, Piacentini R, Fiorita A, Paludetti G, Troiani D (2009) Water-soluble Coenzyme Q10 formulation (Q-ter) promotes outer hair cell survival in a guinea pig model of noise induced hearing loss (NIHL). Brain Res 1257: 108-116.
32. Zmitek J, Smidovnik A, Fir M, Prosek M, Zmitek K, et al. (2008) Relative bioavailability of two forms of a novel water-soluble coenzyme Q10. Ann Nutr Metab 52: 281-287.
33. Zhang Y, Aberg F, Appelkvist EL, Dallner G, Ernster L (1995) Uptake of dietary coenzyme Q supplement is limited in rats. J Nutr 125: 446-453.
34. Carli F, Corvi M, Canal T (2003) Co-grinding process for the preparation of a ternary composition. United States patent application WO 03/097012 A1.
35. Passaquin AC, Renard M, Kay L, Challet C, Mokhtarian A, et al. (2002) Creatine supplementation reduces skeletal muscle degeneration and enhances mitochondrial function in mdx mice. Neuromuscul Disord 12: 174-182.
36. Li XT, Chen R, Jin LM, Chen HY (2009) Regulation on energy metabolism and protection on mitochondria of panax ginseng polysaccharide. Am J Chin Med 37: 1139-1152.
37. Volek JS, Duncan ND, Mazzetti SA, Staron RS, Putukian M, et al. (1999) Performance and muscle fiber adaptations to creatine supplementation and heavy resistance training. Med Sci Sports Exerc 31: 1147-1156.
38. Buford TW, Kreider RB, Stout JR, Greenwood M, Campbell B, et al. (2007) International Society of Sports Nutrition position stand: creatine supplementation and exercise. J Int Soc Sports Nutr 4: 6.
39. Engelhardt M, Neumann G, Berbalk A, Reuter I (1998) Creatine supplementation in endurance sports. Med Sci Sports Exerc 30: 1123-1129.
40. Williams MH, Branch JD (1998) Creatine supplementation and exercise performance: an update. J Am Coll Nutr 17: 216-234.
41. Lawler JM, Barnes WS, Wu G, Song W, Demaree S (2002) Direct antioxidant properties of creatine. Biochem Biophys Res Commun 290: 47-52.
42. Willoughby DS, Rosene J (2001) Effects of oral creatine and resistance training on myosin heavy chain expression. Med Sci Sports Exerc 33: 1674-1681.
43. Willoughby DS, Rosene JM (2003) Effects of oral creatine and resistance training on myogenic regulatory factor expression. Med Sci Sports Exerc 35: 923-929.
44. Adhihetty PJ, Beal MF (2008) Creatine and its potential therapeutic value for targeting cellular energy impairment in neurodegenerative diseases. Neuromolecular Med 10: 275-290.
45. Chaturvedi RK, Beal MF (2008) Mitochondrial approaches for neuroprotection. Ann N Y Acad Sci 1147: 395-412.
46. Dolder M, Walzel B, Speer O, Schlattner U, Wallimann T (2003) Inhibition of the mitochondrial permeability transition by creatine kinase substrates. Requirement for microcompartmentation. J Biol Chem 278: 17760-17766.
47. Fu Y, Ji LL (2003) Chronic ginseng consumption attenuates age-associated oxidative stress in rats. J Nutr 133: 3603-3609.
48. Voces J, Cabral de Oliveira AC, Prieto JG, Vila L, Perez AC, et al. (2004) Ginseng administration protects skeletal muscle from oxidative stress induced by acute exercise in rats. Braz J Med Biol Res 37: 1863-1871.
49. Kennedy DO, Scholey AB (2003) Ginseng: potential for the enhancement of cognitive performance and mood. Pharmacol Biochem Behav 75: 687-700.
50. Qian ZM, Lu J, Gao QP, Li SP (2009) Rapid method for simultaneous determination of flavonoid, saponins and polyacetylenes in folium ginseng and radix ginseng by pressurized liquid extraction and high-performance liquid chromatography coupled with diode array detection and mass spectrometry. J Chromatogr A 1216: 3825-3830.
51. Kim YH, Park KH, Rho HM (1996) Transcriptional activation of the Cu,Znsuperoxide dismutase gene through the AP2 site by ginsenoside Rb2 extracted from a medicinal plant, Panax ginseng. J Biol Chem 271: 24539-24543.
52. Xie XS, Yang M, Liu HC, Zuo C, Li HJ, et al. (2009) Ginsenoside Rg1, a major active component isolated from Panax notoginseng, restrains tubular epithelial to myofibroblast transition in vitro. J Ethnopharmacol 122: 35-41.
53. Cabral de Oliveira AC, Perez AC, Prieto JG, Duarte ID, Alvarez AI (2005) Protection of Panax ginseng in injured muscles after eccentric exercise. J Ethnopharmacol 97: 211-214.
54. Attele AS, Wu JA, Yuan CS (1999) Ginseng pharmacology: multiple constituents and multiple actions. Biochem Pharmacol 58: 1685-1693.
55. Carter CS, Cesari M, Ambrosius WT, Hu N, Diz D, et al. (2004) Angiotensinconverting enzyme inhibition, body composition, and physical performance in aged rats. J Gerontol A Biol Sci Med Sci 59: 416-423.
56. Xu J, Knutson MD, Carter CS, Leeuwenburgh C (2008) Iron accumulation with age, oxidative stress and functional decline. PLoS ONE 3: e2865.
57. Sonntag WE, Carter CS, Ikeno Y, Ekenstedt K, Carlson CS, et al. (2005) Adultonset growth hormone and insulin-like growth factor I deficiency reduces neoplastic disease, modifies age-related pathology, and increases life span. Endocrinology 146: 2920-2932.
58. Boctor SY, Ferguson SA (2010) Altered adult locomotor activity in rats from phencyclidine treatment on postnatal days 7, 9 and 11, but not repeated ketamine treatment on postnatal day 7. Neurotoxicology 31: 42-54.
59. Kehl LJ, Trempe TM, Hargreaves KM (2000) A new animal model for assessing mechanisms and management of muscle hyperalgesia. Pain 85: 333-343.
60. Marzetti E, Groban L, Wohlgemuth SE, Lees HA, Lin M, et al. (2008) Effects of short-term GH supplementation and treadmill exercise training on physical performance and skeletal muscle apoptosis in old rats. Am J Physiol Regul Integr Comp Physiol 294: R558-R567.
61. Hofer T, Servais S, Seo AY, Marzetti E, Hiona A, et al. (2009) Bioenergetics and permeability transition pore opening in heart subsarcolemmal and interfibrillar mitochondria: effects of aging and lifelong calorie restriction. Mech Ageing Dev 130: 297-307.
62. Halestrap AP (2006) Calcium, mitochondria and reperfusion injury: a pore way to die. Biochem Soc Trans 34: 232-237.
63. Hofer T, Seo AY, Prudencio M, Leeuwenburgh C (2006) A method to determine RNA and DNA oxidation simultaneously by HPLC-ECD: greater RNA than DNA oxidation in rat liver after doxorubicin administration. Biol Chem 387: 103-111.
64. Bradford MM (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
65. Benzie IF, Strain JJ (1996) The ferric reducing ability of plasma (FRAP) as a measure of ''antioxidant power'': the FRAP assay. Anal Biochem 239: 70-76.
66. Marzetti E, Leeuwenburgh C (2006) Skeletal muscle apoptosis, sarcopenia and frailty at old age. Exp Gerontol 41: 1234-1238.
67. Goffaux J, Friesinger GC, Lambert W, Shroyer LW, Moritz TE, et al. (2005) Biological age-a concept whose time has come: a preliminary study. South Med J 98: 985-993.
68. Raj IS, Bird SR, Shield AJ (2010) Aging and the force-velocity relationship of muscles. Exp Gerontol 45: 81-90.
69. Kirkland JL, Peterson C (2009) Healthspan, translation, and new outcomes for animal studies of aging. J Gerontol A Biol Sci Med Sci 64: 209-212.
70. Tatar M (2009) Can we develop genetically tractable models to assess healthspan (rather than life span) in animal models? J Gerontol A Biol Sci Med Sci 64: 161-163.
71. Czarkowska-Paczek B, Milczarczyk S (2006) Age-related muscle mass loss. Przegl Lek 63: 658-661.
72. Adhihetty PJ, Ljubicic V, Menzies KJ, Hood DA (2005) Differential susceptibility of subsarcolemmal and intermyofibrillar mitochondria to apoptotic stimuli. Am J Physiol Cell Physiol 289: C994-C1001.
73. Judge S, Jang YM, Smith A, Hagen T, Leeuwenburgh C (2005) Age-associated increases in oxidative stress and antioxidant enzyme activities in cardiac interfibrillar mitochondria: implications for the mitochondrial theory of aging. FASEB J 19: 419-421.
74. Suh JH, Heath SH, Hagen TM (2003) Two subpopulations of mitochondria in the aging rat heart display heterogenous levels of oxidative stress. Free Radic Biol Med 35: 1064-1072.
75. Fannin SW, Lesnefsky EJ, Slabe TJ, Hassan MO, Hoppel CL (1999) Aging selectively decreases oxidative capacity in rat heart interfibrillar mitochondria. Arch Biochem Biophys 372: 399-407.
76. Margetis PI, Antonelou MH, Petropoulos IK, Margaritis LH, Papassideri IS (2009) Increased protein carbonylation of red blood cell membrane in diabetic retinopathy. Exp Mol Pathol 87: 76-82.
77. Mannello F, Tonti GA, Medda V (2009) Protein oxidation in breast microenvironment: Nipple aspirate fluid collected from breast cancer women contains increased protein carbonyl concentration. Cell Oncol 31: 383-392.
78. Chevion M, Berenshtein E, Stadtman ER (2000) Human studies related to protein oxidation: protein carbonyl content as a marker of damage. Free Radic Res 33 Suppl: S99-S108.
79. Feng J, Arriaga EA (2008) Quantification of carbonylated proteins in rat skeletal muscle mitochondria using capillary sieving electrophoresis with laser-induced fluorescence detection. Electrophoresis 29: 475-482.
80. Barreiro E, Hussain SN (2010) Protein carbonylation in skeletal muscles: impact on function. Antioxid Redox Signal 12: 417-429.
81. Shanely RA, Zergeroglu MA, Lennon SL, Sugiura T, Yimlamai T, et al. (2002) Mechanical ventilation-induced diaphragmatic atrophy is associated with oxidative injury and increased proteolytic activity. Am J Respir Crit Care Med 166: 1369-1374.
82. Zergeroglu MA, McKenzie MJ, Shanely RA, Van GD, DeRuisseau KC, et al. (2003) Mechanical ventilation-induced oxidative stress in the diaphragm. J Appl Physiol 95: 1116-1124.
83. Betters JL, Criswell DS, Shanely RA, Van GD, Falk D, et al. (2004) Trolox attenuates mechanical ventilation-induced diaphragmatic dysfunction and proteolysis. Am J Respir Crit Care Med 170: 1179-1184.
84. McClung JM, Whidden MA, Kavazis AN, Falk DJ, DeRuisseau KC, et al. (2008) Redox regulation of diaphragm proteolysis during mechanical ventilation. Am J Physiol Regul Integr Comp Physiol 294: R1608-R1617.
85. Tanaka M, Chock PB, Stadtman ER (2007) Oxidized messenger RNA induces translation errors. Proc Natl Acad Sci U S A 104: 66-71.
86. Campos C, Guzman R, Lopez-Fernandez E, Casado A (2010) Urinary uric acid and antioxidant capacity in children and adults with Down syndrome. Clin Biochem 43: 228-233.
87. Hyun DH, Hernandez JO, Mattson MP, de Cabo R (2006) The plasma membrane redox system in aging. Ageing Res Rev 5: 209-220.
88. Koren E, Lipkin J, Klar A, Hershkovitz E, Ginsburg I, et al. (2009) Total oxidant-scavenging capacities of plasma from glycogen storage disease type Ia patients as measured by cyclic voltammetry, FRAP and luminescence techniques. J Inherit Metab Dis 32: 651-659.
89. Leeuwenburgh C, Hansen PA, Holloszy JO, Heinecke JW (1999) Oxidized amino acids in the urine of aging rats: potential markers for assessing oxidative stress in vivo. Am J Physiol 276: R128-R135.
90. Kirschbaum B (2001) Total urine antioxidant capacity. Clin Chim Acta 305: 167-173.
91. Ghiselli A, Serafini M, Natella F, Scaccini C (2000) Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic Biol Med 29: 1106-1114.